Efecto negativo de la furosemida en el curso de la hemorragia subaracnoidea
Abstract
Se realizó un estudio comparativo de 106 pacientes que presentaban una hemorragia cerebral, fallecidos en el Instituto de Neurología y Neurocirugía; 81 de los cuales estaban bajo tratamiento con furosemida (a 20 de los mismos se les asoció un antibiótico nefrotóxico del tipo ceporán y la gentamicina); el resto no recibió este tipo de medicamento. Se trató de demostrar ei posible daño renal, fundamentalmente tubular, que dicho diurético pudiera provocar, valorándose parámetros clínicos, humorales e hísticos. En nuestro estudio no se verificaron lesiones hísticas renales secundarias a la furosemida ni a los antibióticos potencialmente nefrotóxicos. Resaltamos el valor protector de la furosemida sobre el túbulo renal, cuando es administrado antes que los nefrotóxicos.Downloads
Downloads
Published
How to Cite
Issue
Section
License
The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.
You are free to:
- Share - copy and redistribute the material in any medium or format.
- Adapt - remix, transform and build upon the material
- The license cannot revoke these freedoms as long as you follow the terms of the license.
Under the following terms:
- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.
- Non-Commercial Purpose- You may not make use of the material for commercial purposes.
- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.

